Article Text
Abstract
Physicians engage in risk stratification as a normative part of their professional duties. Risk stratification has the potential to be beneficial in many ways, and implicit recognition of this potential benefit underlies its acceptance as a cornerstone of the medical profession. However, risk stratification also has the potential to be harmful. We argue that ‘profiling’ is a term that corresponds to risk stratification strategies in which there is concern that ethical harms exceed likely or proven benefits. In the case of risk stratification for health goals, this would occur most frequently if benefits were obtained by threats to justice, autonomy or privacy. We discuss implications of the potential overlap between risk stratification and profiling for researchers and for clinicians, and we consider whether there are salient characteristics that make a particular risk stratification algorithm more or less likely to overlap with profiling, such as whether the risk stratification algorithm is based on voluntary versus non-voluntary characteristics, based on causal versus non-causal characteristics, or based on signifiers of historical disadvantage. We also discuss the ethical challenges created when a risk stratification scheme helps all subgroups but some more than others, or when risk stratification harms some subgroups but benefits the aggregate group.
- Decision-making
- Ethics
Statistics from Altmetric.com
Linked Articles
- Public health ethics
Read the full text or download the PDF:
Other content recommended for you
- Age and sex specific thresholds for risk stratification of cardiovascular disease and clinical decision making: prospective open cohort study
- Risk assessment and stratification of mild cognitive impairment among the Chinese elderly: attention to modifiable risk factors
- Prevention of sudden cardiac death in hypertrophic cardiomyopathy
- A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
- Is health profiling morally permissible?
- Which strings attached: ethical considerations for selecting appropriate conditionalities in conditional cash transfer programmes
- Risk factors, risk stratification and risk-specific surveillance strategies after endovascular aneurysm repair: study protocol for a Delphi study by the International RIsk Stratification in EVAR (IRIS-EVAR) working group
- Commercial surrogacy: how provisions of monetary remuneration and powers of international law can prevent exploitation of gestational surrogates
- Fair and equitable subject selection in concurrent COVID-19 clinical trials
- Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?